Correlation Between Unicycive Therapeutics and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Tscan Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Tscan Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Tscan Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Tscan is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Tscan Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.72 times more return on investment than Tscan Therapeutics. However, Unicycive Therapeutics is 1.38 times less risky than Tscan Therapeutics. It trades about 0.38 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 53.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 27.00 from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Tscan Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Tscan Therapeutics |
Unicycive Therapeutics and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Tscan Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |